BRIEF-Stellar Biotechnologies and Neovacs expand KLH supply relationship
April 1 (Reuters) - Neovacs SA :
* Says expands KLH supply relationship with Stellar Biotechnologies
* Companies sign KLH supply agreement for Neovacs' kinoid clinical trials and initial commercialization
* Companies have entered into an expanded supply agreement to meet Neovacs' requirements for keyhole limpet hemocyanin (KLH) Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
© Thomson Reuters 2017 All rights reserved.